-
Je něco špatně v tomto záznamu ?
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
M. Sokolowska, GE. Rovati, Z. Diamant, E. Untersmayr, J. Schwarze, Z. Lukasik, F. Sava, A. Angelina, O. Palomares, CA. Akdis, L. O'Mahony, M. Sanak, SE. Dahlen, G. Woszczek
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
G0900536
Medical Research Council - United Kingdom
G1000758
Medical Research Council - United Kingdom
MC_PC_15031
Medical Research Council - United Kingdom
PubMed
32279330
DOI
10.1111/all.14295
Knihovny.cz E-zdroje
- MeSH
- alergie * MeSH
- bronchiální astma * etiologie MeSH
- ikosanoidy MeSH
- konsensus MeSH
- leukotrieny MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Eicosanoids are biologically active lipid mediators, comprising prostaglandins, leukotrienes, thromboxanes, and lipoxins, involved in several pathophysiological processes relevant to asthma, allergies, and allied diseases. Prostaglandins and leukotrienes are the most studied eicosanoids and established inducers of airway pathophysiology including bronchoconstriction and airway inflammation. Drugs inhibiting the synthesis of lipid mediators or their effects, such as leukotriene synthesis inhibitors, leukotriene receptors antagonists, and more recently prostaglandin D2 receptor antagonists, have been shown to modulate features of asthma and allergic diseases. This review, produced by an European Academy of Allergy and Clinical Immunology (EAACI) task force, highlights our current understanding of eicosanoid biology and its role in mediating human pathology, with a focus on new findings relevant for clinical practice, development of novel therapeutics, and future research opportunities.
Centre for Allergy Research Karolinska Institute Stockholm Sweden
Child Life and Health and Centre for Inflammation Research The University of Edinburgh Edinburgh UK
Christine Kühne Center for Allergy Research and Education Davos Switzerland
Department of Medicine Jagiellonian University Medical College Krakow Poland
Department of Pharmaceutical Sciences University of Milan Milan Italy
Department of Respiratory Medicine and Allergology Skane University Hospital Lund Sweden
Departments of Medicine and Microbiology APC Microbiome Ireland University College Cork Cork Ireland
Institute of Environmental Medicine Karolinska Institute Stockholm Sweden
Swiss Institute of Allergy and Asthma Research University of Zurich Davos Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019494
- 003
- CZ-PrNML
- 005
- 20210830101058.0
- 007
- ta
- 008
- 210728s2021 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/all.14295 $2 doi
- 035 __
- $a (PubMed)32279330
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Sokolowska, Milena $u Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland $u Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland
- 245 10
- $a Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I / $c M. Sokolowska, GE. Rovati, Z. Diamant, E. Untersmayr, J. Schwarze, Z. Lukasik, F. Sava, A. Angelina, O. Palomares, CA. Akdis, L. O'Mahony, M. Sanak, SE. Dahlen, G. Woszczek
- 520 9_
- $a Eicosanoids are biologically active lipid mediators, comprising prostaglandins, leukotrienes, thromboxanes, and lipoxins, involved in several pathophysiological processes relevant to asthma, allergies, and allied diseases. Prostaglandins and leukotrienes are the most studied eicosanoids and established inducers of airway pathophysiology including bronchoconstriction and airway inflammation. Drugs inhibiting the synthesis of lipid mediators or their effects, such as leukotriene synthesis inhibitors, leukotriene receptors antagonists, and more recently prostaglandin D2 receptor antagonists, have been shown to modulate features of asthma and allergic diseases. This review, produced by an European Academy of Allergy and Clinical Immunology (EAACI) task force, highlights our current understanding of eicosanoid biology and its role in mediating human pathology, with a focus on new findings relevant for clinical practice, development of novel therapeutics, and future research opportunities.
- 650 12
- $a bronchiální astma $x etiologie $7 D001249
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a ikosanoidy $7 D015777
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a alergie $7 D006967
- 650 _2
- $a leukotrieny $7 D015289
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rovati, G Enrico $u Department of Pharmaceutical Sciences, University of Milan, Milan, Italy
- 700 1_
- $a Diamant, Zuzana $u Department of Respiratory Medicine & Allergology, Skane University Hospital, Lund, Sweden $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
- 700 1_
- $a Untersmayr, Eva $u Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Schwarze, Jargen $u Child Life and Health and Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK
- 700 1_
- $a Lukasik, Zuzanna $u Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland
- 700 1_
- $a Sava, Florentina $u London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK
- 700 1_
- $a Angelina, Alba $u Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain
- 700 1_
- $a Palomares, Oscar $u Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University, Madrid, Spain
- 700 1_
- $a Akdis, Cezmi A $u Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland $u Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland
- 700 1_
- $a O'Mahony, Liam $u Departments of Medicine and Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland
- 700 1_
- $a Sanak, Marek $u Department of Medicine, Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Dahlen, Sven-Erik $u Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden $u Centre for Allergy Research, Karolinska Institute, Stockholm, Sweden
- 700 1_
- $a Woszczek, Grzegorz $u MRC/Asthma UK Centre in Allergic Mechanisms of Asthma, School of Immunology & Microbial Sciences, King's College London, London, UK
- 773 0_
- $w MED00009088 $t Allergy $x 1398-9995 $g Roč. 76, č. 1 (2021), s. 114-130
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32279330 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101058 $b ABA008
- 999 __
- $a ok $b bmc $g 1690341 $s 1139940
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 76 $c 1 $d 114-130 $e - $i 1398-9995 $m Allergy $n Allergy $x MED00009088
- GRA __
- $a G0900536 $p Medical Research Council $2 United Kingdom
- GRA __
- $a G1000758 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MC_PC_15031 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20210728